News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Pharmaceutical (JPN) And Sankyo Company, Ltd. (SKXOF.PK) Sign Basic Agreement To Integrate Businesses; Joint Holding Company To Be Established In October



10/19/2005 5:12:51 PM

TOKYO--(BUSINESS WIRE)--Feb. 25, 2005--Daiichi Pharmaceutical Co., Ltd. ("Daiichi") (President and Representative Director, Kiyoshi Morita) and Sankyo Co., Ltd. ("Sankyo") (President and Representative Director, Takashi Shoda) announced today they have concluded a basic agreement to integrate their businesses commencing October 2005. Resolutions by the Boards of both companies approved this agreement earlier today. Kiyoshi Morita, President and CEO of Daiichi commented, "The integration of our two businesses will enable us to achieve a level of growth and a range of opportunities that would be out of our reach individually."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES